{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:37:54Z","timestamp":1790674674308,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"The Cure Huntington's Disease Initiative (CHDI)","award":["A-5303"],"award-info":[{"award-number":["A-5303"]}]},{"DOI":"10.13039\/501100003653","name":"National Institute of Health","doi-asserted-by":"publisher","award":["NS030687"],"award-info":[{"award-number":["NS030687"]}],"id":[{"id":"10.13039\/501100003653","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003653","name":"National Institute of Health","doi-asserted-by":"publisher","award":["NS064114"],"award-info":[{"award-number":["NS064114"]}],"id":[{"id":"10.13039\/501100003653","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003653","name":"National Institute of Health","doi-asserted-by":"publisher","award":["HL96571"],"award-info":[{"award-number":["HL96571"]}],"id":[{"id":"10.13039\/501100003653","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003653","name":"National Institute of Health","doi-asserted-by":"publisher","award":["HL098351"],"award-info":[{"award-number":["HL098351"]}],"id":[{"id":"10.13039\/501100003653","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003653","name":"National Institute of Health","doi-asserted-by":"publisher","award":["DA08259"],"award-info":[{"award-number":["DA08259"]}],"id":[{"id":"10.13039\/501100003653","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.nbd.2015.08.008","type":"journal-article","created":{"date-parts":[[2015,8,15]],"date-time":"2015-08-15T13:46:11Z","timestamp":1439646371000},"page":"466-477","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Selective reduction of striatal mature BDNF without induction of proBDNF in the zQ175 mouse model of Huntington's disease"],"prefix":"10.1016","volume":"82","author":[{"given":"Qian","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianmin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa A.","family":"Milner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara L.","family":"Hempstead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2015.08.008_bb0005","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/39885","article-title":"Anterograde transport of brain-derived neurotrophic factor and its role in the brain","volume":"389","author":"Altar","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2015.08.008_bb0010","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1038\/ncomms3490","article-title":"Val66Met polymorphism of BDNF alters prodomain structure to induce neuronal growth cone retraction","volume":"4","author":"Anastasia","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nbd.2015.08.008_bb0015","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1523\/JNEUROSCI.3920-03.2004","article-title":"Early striatal dendrite deficits followed by neuron loss with advanced age in the absence of anterograde cortical brain-derived neurotrophic factor","volume":"24","author":"Baquet","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.08.008_bb0020","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1007\/s11064-007-9352-7","article-title":"Myelin breakdown and iron changes in Huntington's disease: pathogenesis and treatment implications","volume":"32","author":"Bartzokis","year":"2007","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.nbd.2015.08.008_bb0025","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0896-6273(02)01005-X","article-title":"ProNGF induces p75-mediated death of oligodendrocytes following spinal cord injury","volume":"36","author":"Beattie","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2015.08.008_bb0030","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1089\/10430349950016393","article-title":"Brain-derived neurotrophic factor-mediated protection of striatal neurons in an excitotoxic rat model of Huntington's disease, as demonstrated by adenoviral gene transfer","volume":"10","author":"Bemelmans","year":"1999","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.nbd.2015.08.008_bb0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020696","article-title":"Hdac6 knock-out increases tubulin acetylation but does not modify disease progression in the R6\/2 mouse model of Huntington's disease","volume":"6","author":"Bobrowska","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.nbd.2015.08.008_bb0040","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.mcn.2010.07.009","article-title":"LINGO-1-mediated inhibition of oligodendrocyte differentiation does not require the leucine-rich repeats and is reversed by p75(NTR) antagonists","volume":"45","author":"Bourikas","year":"2010","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.nbd.2015.08.008_bb0045","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.116","article-title":"Imbalance of p75(NTR)\/TrkB protein expression in Huntington's disease: implication for neuroprotective therapies","volume":"4","author":"Brito","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.nbd.2015.08.008_bb0050","doi-asserted-by":"crossref","first-page":"7727","DOI":"10.1523\/JNEUROSCI.1197-04.2004","article-title":"Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease","volume":"24","author":"Canals","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.08.008_bb0055","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/383716a0","article-title":"Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75","volume":"383","author":"Casaccia-Bonnefil","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2015.08.008_bb0060","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/nrn1806","article-title":"Normal huntingtin function: an alternative approach to Huntington's disease","volume":"6","author":"Cattaneo","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2015.08.008_bb0065","doi-asserted-by":"crossref","first-page":"6404","DOI":"10.1523\/JNEUROSCI.20-17-06404.2000","article-title":"NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions","volume":"20","author":"Chang","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.08.008_bb0070","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.celrep.2012.11.009","article-title":"Genetic dissection of neurotrophin signaling through the p75 neurotrophin receptor","volume":"2","author":"Charalampopoulos","year":"2012","journal-title":"Cell Rep."},{"key":"10.1016\/j.nbd.2015.08.008_bb0075","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/gt.2012.84","article-title":"In vivo delivery of DN:REST improves transcriptional changes of REST-regulated genes in HD mice","volume":"20","author":"Conforti","year":"2013","journal-title":"Gene Ther."},{"key":"10.1016\/j.nbd.2015.08.008_bb0080","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.neuron.2010.12.035","article-title":"Huntington's disease: can mice lead the way to treatment?","volume":"69","author":"Crook","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2015.08.008_bb0085","doi-asserted-by":"crossref","first-page":"ra82","DOI":"10.1126\/scisignal.2002060","article-title":"Neuronal growth cone retraction relies on proneurotrophin receptor signaling through Rac","volume":"4","author":"Deinhardt","year":"2011","journal-title":"Sci. Signal."},{"key":"10.1016\/j.nbd.2015.08.008_bb0090","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.mcn.2005.11.001","article-title":"Distinct effects of p75 in mediating actions of neurotrophins on basal forebrain oligodendrocytes","volume":"31","author":"Du","year":"2006","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.nbd.2015.08.008_bb0095","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1523\/JNEUROSCI.16-10-03123.1996","article-title":"Naturally occurring truncated trkB receptors have dominant inhibitory effects on brain-derived neurotrophic factor signaling","volume":"16","author":"Eide","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.08.008_bb0100","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0006-8993(00)02237-X","article-title":"Brain-derived neurotrophic factor in Huntington disease","volume":"866","author":"Ferrer","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2015.08.008_bb0105","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cell.2004.06.018","article-title":"Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules","volume":"118","author":"Gauthier","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2015.08.008_bb0110","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1471-4159.2007.05137.x","article-title":"Brain-derived neurotrophic factor over-expression in the forebrain ameliorates Huntington's disease phenotypes in mice","volume":"105","author":"Gharami","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2015.08.008_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064037","article-title":"Systemic delivery of recombinant brain derived neurotrophic factor (BDNF) in the R6\/2 mouse model of Huntington's disease","volume":"8","author":"Giampa","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.nbd.2015.08.008_bb0120","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/hmg\/ddg046","article-title":"Specific progressive cAMP reduction implicates energy deficit in presymptomatic Huntington's disease knock-in mice","volume":"12","author":"Gines","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2015.08.008_bb0125","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's disease collaborative research group","volume":"72","author":"HDCRG","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2015.08.008_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050717","article-title":"Characterization of neurophysiological and behavioral changes, MRI brain volumetry and 1H MRS in zQ175 knock-in mouse model of Huntington's disease","volume":"7","author":"Heikkinen","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.nbd.2015.08.008_bb0135","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1093\/hmg\/ddv016","article-title":"Early white matter abnormalities, progressive brain pathology and motor deficits in a novel knock-in mouse model of Huntington's disease","volume":"24","author":"Jin","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2015.08.008_bb0140","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/nn.3357","article-title":"Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis","volume":"16","author":"Kang","year":"2013","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2015.08.008_bb0150","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.ymthe.2004.02.016","article-title":"AAV-mediated gene delivery of BDNF or GDNF is neuroprotective in a model of Huntington disease","volume":"9","author":"Kells","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.nbd.2015.08.008_bb0145","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/gt.2008.23","article-title":"AAV\u2013BDNF mediated attenuation of quinolinic acid-induced neuropathology and motor function impairment","volume":"15","author":"Kells","year":"2008","journal-title":"Gene Ther."},{"key":"10.1016\/j.nbd.2015.08.008_bb0155","doi-asserted-by":"crossref","first-page":"6298","DOI":"10.1523\/JNEUROSCI.2033-12.2013","article-title":"Mutant Huntingtin alters retrograde transport of TrkB receptors in striatal dendrites","volume":"33","author":"Liot","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.08.008_bb0160","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1602\/neurorx.2.3.465","article-title":"Knock-in mouse models of Huntington's disease","volume":"2","author":"Menalled","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.nbd.2015.08.008_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049838","article-title":"Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington's disease: zQ175","volume":"7","author":"Menalled","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.nbd.2015.08.008_bb0170","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nn1188","article-title":"LINGO-1 is a component of the Nogo-66 receptor\/p75 signaling complex","volume":"7","author":"Mi","year":"2004","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2015.08.008_bb0175","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/nn1460","article-title":"LINGO-1 negatively regulates myelination by oligodendrocytes","volume":"8","author":"Mi","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2015.08.008_bb0180","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/978-1-61779-328-8_3","article-title":"Degenerating processes identified by electron microscopic immunocytochemical methods","volume":"793","author":"Milner","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.nbd.2015.08.008_bb0185","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/glia.20056","article-title":"Expression of the low-affinity neurotrophin receptor, p75(NTR), is upregulated by oligodendroglial progenitors adjacent to the subventricular zone in response to demyelination","volume":"48","author":"Petratos","year":"2004","journal-title":"Glia"},{"key":"10.1016\/j.nbd.2015.08.008_bb0190","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuron.2014.05.032","article-title":"Impaired TrkB receptor signaling underlies corticostriatal dysfunction in Huntington's disease","volume":"83","author":"Plotkin","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2015.08.008_bb0195","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0092-8674(00)81782-1","article-title":"Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions","volume":"95","author":"Saudou","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2015.08.008_bb0200","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1093\/hmg\/ddn211","article-title":"Compensatory changes in the ubiquitin-proteasome system, brain-derived neurotrophic factor and mitochondrial complex II\/III in YAC72 and R6\/2 transgenic mice partially model Huntington's disease patients","volume":"17","author":"Seo","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2015.08.008_bb0205","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1146\/annurev.me.26.020175.002223","article-title":"Huntington's disease","volume":"26","author":"Shoulson","year":"1975","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.nbd.2015.08.008_bb0210","doi-asserted-by":"crossref","first-page":"18712","DOI":"10.1523\/JNEUROSCI.1310-13.2013","article-title":"A small molecule TrkB ligand reduces motor impairment and neuropathology in R6\/2 and BACHD mouse models of Huntington's disease","volume":"33","author":"Simmons","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.08.008_bb0215","doi-asserted-by":"crossref","first-page":"4510","DOI":"10.1093\/hmg\/ddu166","article-title":"Progressive axonal transport and synaptic protein changes correlate with behavioral and neuropathological abnormalities in the heterozygous Q175 KI mouse model of Huntington's disease","volume":"23","author":"Smith","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2015.08.008_bb0220","doi-asserted-by":"crossref","first-page":"11109","DOI":"10.1523\/JNEUROSCI.0895-12.2012","article-title":"Methylene blue modulates huntingtin aggregation intermediates and is protective in Huntington's disease models","volume":"32","author":"Sontag","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.08.008_bb0225","doi-asserted-by":"crossref","first-page":"11758","DOI":"10.1523\/JNEUROSCI.2461-07.2007","article-title":"Expression profiling of Huntington's disease models suggests that brain-derived neurotrophic factor depletion plays a major role in striatal degeneration","volume":"27","author":"Strand","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.08.008_bb0230","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.lfs.2012.04.038","article-title":"Sortilin is required for toxic action of Abeta oligomers (AbetaOs): extracellular AbetaOs trigger apoptosis, and intraneuronal AbetaOs impair degradation pathways","volume":"91","author":"Takamura","year":"2012","journal-title":"Life Sci."},{"key":"10.1016\/j.nbd.2015.08.008_bb0235","doi-asserted-by":"crossref","first-page":"5455","DOI":"10.1523\/JNEUROSCI.5123-04.2005","article-title":"ProBDNF induces neuronal apoptosis via activation of a receptor complex of p75NTR and sortilin","volume":"25","author":"Teng","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.08.008_bb0240","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1002\/glia.20533","article-title":"The neurotrophin receptor p75NTR in Schwann cells is implicated in remyelination and motor recovery after peripheral nerve injury","volume":"55","author":"Tomita","year":"2007","journal-title":"Glia"},{"key":"10.1016\/j.nbd.2015.08.008_bb0245","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/nn.3691","article-title":"Astrocyte Kir4.1 ion channel deficits contribute to neuronal dysfunction in Huntington's disease model mice","volume":"17","author":"Tong","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2015.08.008_bb0250","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","article-title":"Huntington's disease","volume":"369","author":"Walker","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.nbd.2015.08.008_bb0255","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/nature01176","article-title":"P75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgp","volume":"420","author":"Wang","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2015.08.008_bb0260","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nn1510","article-title":"Activation of p75NTR by proBDNF facilitates hippocampal long-term depression","volume":"8","author":"Woo","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2015.08.008_bb0265","doi-asserted-by":"crossref","first-page":"9544","DOI":"10.1523\/JNEUROSCI.1291-11.2011","article-title":"Peroxisome-proliferator-activated receptor gamma coactivator 1 alpha contributes to dysmyelination in experimental models of Huntington's disease","volume":"31","author":"Xiang","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.08.008_bb0270","doi-asserted-by":"crossref","first-page":"14708","DOI":"10.1523\/JNEUROSCI.1637-10.2010","article-title":"BDNF overexpression in the forebrain rescues Huntington's disease phenotypes in YAC128 mice","volume":"30","author":"Xie","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.08.008_bb0275","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nn.2244","article-title":"Neuronal release of proBDNF","volume":"12","author":"Yang","year":"2009","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2015.08.008_bb0280","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.celrep.2014.03.040","article-title":"proBDNF negatively regulates neuronal remodeling, synaptic transmission, and synaptic plasticity in hippocampus","volume":"7","author":"Yang","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.nbd.2015.08.008_bb0300","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1126\/science.1059581","article-title":"Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease","volume":"293","author":"Zuccato","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.nbd.2015.08.008_bb0295","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/ng1219","article-title":"Huntingtin interacts with REST\/NRSF to modulate the transcription of NRSE-controlled neuronal genes","volume":"35","author":"Zuccato","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2015.08.008_bb0290","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.phrs.2005.01.001","article-title":"Progressive loss of BDNF in a mouse model of Huntington's disease and rescue by BDNF delivery","volume":"52","author":"Zuccato","year":"2005","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.nbd.2015.08.008_bb0285","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1750-3639.2007.00111.x","article-title":"Systematic assessment of BDNF and its receptor levels in human cortices affected by Huntington's disease","volume":"18","author":"Zuccato","year":"2008","journal-title":"Brain Pathol."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996115300292?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996115300292?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,26]],"date-time":"2018-10-26T19:50:40Z","timestamp":1540583440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996115300292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":60,"alternative-id":["S0969996115300292"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2015.08.008","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selective reduction of striatal mature BDNF without induction of proBDNF in the zQ175 mouse model of Huntington's disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2015.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}